Particularly relevant is the molecular classification that divides breast cancer into four major subtypes: Luminal A, Luminal B, HER2-enriched (HER2+), and triple-negative breast cancer (TNBC) [12,13]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.